Prospective, randomized, double-blind, placebo-controlled phase IIa clinical trial on the effects of an estrogen-progestin combination as add-on to inpatient psychotherapy in adult female patients suffering from anorexia nervosa.
Georgios PaslakisStefanie MaasBernd GebhardtAndreas MayrManfred RauhYesim ErimPublished in: BMC psychiatry (2018)
European Clinical Trials Database, EudraCT number 2015-004184-36, registered November 2015; ClinicalTrials.gov Identifier: NCT03172533 , retrospectively registered May 2017.
Keyphrases
- double blind
- clinical trial
- placebo controlled
- phase ii
- phase iii
- anorexia nervosa
- study protocol
- open label
- end stage renal disease
- ejection fraction
- newly diagnosed
- phase ii study
- squamous cell carcinoma
- randomized controlled trial
- palliative care
- prognostic factors
- peritoneal dialysis
- mental health
- young adults
- drug induced